FDA Inspection
SightLife/CorneaGenSightLife/CorneaGen – FDA Inspection, Sep 21, 2011
Record Details
This FDA Inspection record concerns SightLife/CorneaGen, with an inspection on September 21, 2011, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- SightLife/CorneaGen
- Inspection Date
- September 21, 2011
- Product Type
- Biologics
View Company Profile
ID · 2efc6678-4dd1-45e1-8d10-2c678f14cac8
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 745752
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of SightLife/CorneaGen
3| Date | Classification | Office | Project area |
|---|---|---|---|
| August 3, 2016 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| September 11, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| March 26, 2009 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for SightLife/CorneaGen
- FDA Inspection 981753 - 2016-08-03
- FDA Inspection 894961 - 2014-09-11
- FDA Inspection 572644 - 2009-03-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.